Company Overview: Inventus Mining Corp. (TSXV: IVS) is an early-stage gold and critical minerals exploration company focused on the prolific Sudbury Mining District in Ontario, Canada. The company owns 100% of its two flagship assets, providing full exposure to exploration success without joint venture dilution. Tenaya Therapeutics, Inc. (NASDAQ: TNYA) is a clinical-stage biotechnology company focused on discovering, developing, and delivering potentially curative therapies that address the underlying causes of heart disease. The company leverages advanced gene therapy, cell regeneration, and precision medicine technologies to develop innovative treatments for cardiovascular disorders with significant unmet medical needs. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks. 

Global Markets Wrap-Up

U.S. equity markets ended the week on a mixed note, with major indices delivering varied performances. The S&P 500 advanced 0.20% to close at 7,533.77, supported by strength across several key sectors, which helped maintain positive overall market sentiment. Meanwhile, the technology-heavy NASDAQ Composite underperformed, declining 1.47% to finish at 25,881.95, as continued weakness in large-cap technology stocks weighed on the index. The Russell 2000 also lagged its peers, slipping 0.11% to close at 2,974.57, reflecting relatively softer performance among small-cap stocks.

In Canada, the S&P/TSX Venture Composite Index declined 5.70% on a week-to-date basis to close at 854.37, reflecting weaker near-term market momentum. Strength in the technology and financials sectors provided partial support, highlighting selective investor interest in relatively resilient areas of the market. However, persistent weakness across the basic materials, consumer non-cyclicals, industrials, and energy sectors weighed on overall index performance, limiting broader market participation. The mixed sector performance suggests that, while the broader market structure remains relatively constructive, investor sentiment has become more cautious. Market participants appear to be awaiting stronger and more sustained buying interest before adopting a more aggressive risk-on stance.

Past performance is not a reliable indicator of future performance.